Eprosartan
Back to searchMolecule Structure
Scientific Name
Eprosartan
Description of the Drug
Eprosartan is an ARB used to treat hypertension, diabetic nephropathy, and congestive heart failure.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00876
http://www.drugbank.ca/drugs/DB00876
Brand Name(s)
Teveten
Company Owner(s)
Abbvie Inc, Mylan Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Type-1 angiotensin II receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL227 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4025 | ||
Human Metabolome Database | HMDB0015014 | ||
DrugBank | DB00876 | ||
PubChem: Thomson Pharma | 14929623 | ||
PubChem | 5281037 | ||
Mcule | MCULE-1909746156 | ||
LINCS | LSM-43101 | ||
Nikkaji | J553.931E | J380.264G | |
BindingDB | 50011977 | ||
EPA CompTox Dashboard | DTXSID0022989 | ||
DrugCentral | 1037 | ||
Brenda | 255908 | 27440 | |
ChemicalBook | CB0135346 | ||
Guide to Pharmacology | 3940 | 588 | |
rxnorm | TEVETEN | EPROSARTAN MESYLATE | EPROSARTAN |
ChEBI | 4814 | ||
ZINC | ZINC000029319828 |